Purpose: To implement a dynamic contrast-based multi-echo MRI sequence in assessment of rectal cancer and evaluate associations between histopathologic data and the acquired dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) -MRI parameters. Materials and Methods: This pilot study reports results from 17 patients with resectable rectal cancer. Dynamic contrast-based multi-echo MRI (1.5T) was acquired using a three-dimensional multi-shot EPI sequence, yielding both DCE-and DSC-data following a single injection of contrast agent. The Institutional Review Board approved the study and all patients provided written informed consent. Quantitative analysis was performed by pharmacokinetic modeling on DCE data and tracer kinetic modeling on DSC data. Mann-Whitney U-test and receiver operating characteristics curve statistics was used to evaluate associations between histopathologic data and the acquired DCE-and DSC-MRI parameters. Results: For patients with histologically confirmed nodal metastasis, the primary tumor demonstrated a significantly lower K trans and peak change in R Ã 2 , R Ã 2 -peak enh , than patients without nodal metastasis, showing a P-value of 0.010 and 0.005 for reader 1, and 0.043 and 0.019 for reader 2, respectively. Conclusion: This study shows the feasibility of acquiring DCE-and DSC-MRI in rectal cancer by dynamic multi-echo MRI. A significant association was found between both K trans and R Ã 2 -peak enh in the primary tumor and histological nodal status of the surgical specimen, which may improve stratification of patients to intensified multimodal treatment.
C urrent international guidelines recommend MRI as part of primary staging of rectal cancer. 1 MRI helps identify patients with increased risk of local recurrence and the need of neoadjuvant chemoradiotherapy (CRT). 2 Despite improvements in multimodal rectal cancer management during the past decades, with local recurrence rates below 10%, 3 a considerable number of patients experience poor disease outcome resulting from metastatic disease progression. 4 Reliable detection of metastatic lymph nodes (N1 stage), a main prognostic indicator of distant metastasis, is still a challenge in rectal cancer MRI. At present, the most accurate criterion is the morphological finding of irregular-contoured nodes with mixed signal intensities in T 2 -weighted MR images. However, these MRI findings are associated with substantial misinterpretation and the diagnostic accuracy is relatively poor. A recent meta-analysis of 21 clinical studies showed a diagnostic accuracy for lymph node staging of 71%. 5 To improve the ability of MRI to predict patients at risk of developing metastatic disease, considerable interest is focusing on the tumor microenvironment. Dynamic contrastbased MRI is an increasingly popular method for tumor characterization, enabling quantitative assessment of phenotypic properties. 6 The most commonly used dynamic acquisition is dynamic contrast-enhanced (DCE) MRI, enabling assessment of tissue properties such as capillary permeability and extracellular volume fraction. 7 There is currently no consensus concerning the role of DCE-MRI in rectal cancer patients.
However, according to a recent study, this technique may improve the detection of nodal metastasis. 8 Dynamic susceptibility contrast (DSC) MRI is most commonly used to measure perfusion in the brain. 9 However, studies have also shown the feasibility of using this approach to assess microvasculature in rectal cancer 10 and phenotypic characteristics of breast tumors. [11] [12] [13] Recognizing that rectal tumors are highly angiogenic, it is hypothesized that DSC-MRI may provide valuable information for assessing pathophysiological properties in this patient group. Multiple echoes can be acquired in a high temporal resolution dynamic contrast-based MRI sequence, allowing quantitative measurements of the dynamic change in both longitudinal (R 1 5 1/T 1 ) and transverse relaxation rate (R Ã 2 5 1/T Ã 2 ). As a result, DCE-and DSC-data can be obtained during a single dynamic examination, thus yielding information on pathophysiological properties related to both tissue-permeability and perfusion. In earlier studies, the feasibility of a multi-echo MRI technique has been demonstrated through both simulations and in the assessment of breast cancer. 14, 15 The use of dynamic multi-echo imaging for combined DCE-and DSC-MRI analysis have also been demonstrated in brain tumors. [16] [17] [18] The aim of this pilot study was to implement a dynamic contrast-based multi-echo MRI sequence in the assessment of rectal cancer, and to evaluate associations between histopathologic data and the attainable DCE-and DSC-MRI parameters.
Materials and Methods

Study Patients
The investigation was performed within a prospective biomarker study approved by the Institutional Review Board and the Regional Committee for Medical and Health Research Ethics. The study was performed in accordance with the Helsinki declaration. Written informed consent was obtained for all patients before participation.
The principal inclusion criterion was histologically confirmed rectal cancer scheduled to radical treatment. The patient cohort within the present study was enrolled between March 2014 and June 2015 and all cases had primary pelvic surgery without neoadjuvant CRT. The study cohort included two patients with a preoperative staging of T4 disease and five patients with a preoperative staging of T3N1 disease. According to national guidelines, one patient did not receive neoadjuvant CRT due to age (above 75 years) and frailty. The other T4 case was not accepted for CRT by the regional radiotherapy center. In six patients with N1 disease, the lymph node had a margin of more than 2 mm from the mesorectal fascia; hence, these were also referred to surgery without neoadjuvant CRT. The resected tumor specimens underwent standard histopathologic staging (pTN), including determination of the absence or presence of extramural venous invasion. Patient and tumor characteristics are provided in Table 1 .
MRI Acquisition
In this pilot study, 24 patients were examined, of which five were excluded because of bowel motion and two because of image artifacts. Imaging was performed on a Philips Achieva 1.5 Tesla (T) system (Philips Healthcare, Best, The Netherlands) with NOVA Dual HP gradients (33 mT/m maximum gradient amplitude, 180 T/m/s slew rate). A five-channel cardiac coil with parallel imaging capabilities was applied. To reduce bowel peristalsis, glucagon (1 mg/mL, 1 mL intramuscularly) and BuscopanV R (20 mg/mL, 1 mL intravenously) were given immediately before the patient was centered in the scanner. The dose of BuscopanV R was divided in two; giving half the dose together with the glucagon and the second half before the dynamic contrast-based MRI acquisition. Conventional high-resolution fast spin-echo T 2 -weighted images of the pelvic cavity and rectum were obtained in the sagittal and transversal planes as well as perpendicular to the tumor axis (repetition time (TR) 5 2820-3040 ms; echo time (TE) 5 80 ms; acquisition matrix 5 256 3 230; slice thickness 5 2.5 mm; number of averages 5 6; and echo train length 5 20) .
Dynamic contrast-based multi-echo data were acquired by a three-dimensional (3D) T 1 -weighted multi-shot EPI sequence with three echoes. TR 5 39 ms, TE1 5 4.6 ms, echo spacing 5 9.3 ms, flip angle 5 28 8, EPI factor 5 9. The acquired matrix size was 92 3 90 over a 180 3 180 mm field of view. Twelve slices were acquired with a thickness of 10 mm. The temporal resolution was approximately 2 s/ imaging volume with 60 dynamic series acquired. A ProSet fat suppression technique was applied along with a parallel imaging (SENSE) factor of 1.7 in the RL direction. All slices were acquired parallel to the T 2 -weighted images perpendicular to the tumor axis.
The dynamic multi-echo sequence was interleaved with a high spatial resolution 3D T 1 -weighted TFE sequence (THRIVE), as part of a split-dynamic MRI framework detailed in a recent study.
14 In this framework, one set of THRIVE baseline images was initially acquired. The dynamic multi-echo sequence was then started and five to seven baseline acquisitions were obtained before contrast agent (CA) administration. The multi-echo acquisition was repeated approximately 30 times during the wash-in phase, immediately followed by the first postcontrast THRIVE acquisition. During the intermediate and late postcontrast phase, six split sessions were conducted, each containing four multi-echo acquisitions and one THRIVE acquisition. In addition, a series of 14 multi-echo acquisitions were obtained after the last THRIVE acquisition to improve curve fitting for kinetic modeling. To avoid non-steady state effects, dummy repetitions (i.e., no data sampling) were run for 2500 ms at the beginning of each multi-echo segment. Only results from the dynamic multi-echo data are reported in this work. A dose of 0.2 mL/kg body weight of gadolinium-based CA (DotaremV R 279.3 mg/mL, Guerbet, Roissy, France) was injected as a bolus (3 mL/s) directly followed by 20 mL of physiologic saline solution.
Given that the multi-echo acquisition was run as part of a split-dynamic MRI framework, simulations were performed to investigate whether the splitting of dynamic time-series influences the reliability of parameter estimation in comparison with a continous acquisition. The simulations are described in Appendix A.
Image Analysis
Diagnostic radiological TNM stages were assessed according to international guidelines and the 7 th edition TNM staging system.
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Guided by T 2 -weighted and diffusion-weighted images, two radiologists with 14 (A.N.) and 7 (S.H.H.) years of experience independently contoured whole-tumor volumes of interest (VOIs) by means of free-hand delineations.
Image postprocessing was performed using the nordicICE software (NordicNeuroLab, Bergen, Norway). The dynamic change in R 1 , DR 1 , was estimated using the spoiled gradient echo (SPGR) signal equation, denoted S SPGR (t), assuming a linear relationship between the CA concentration and change in R 1 (1/T 1 ):
where r 1 is the longitudinal relaxivity of the CA and T 1,0 is the T 1 of the tissue in the absent of CA. A similar linear relationship (described by r Ã 2 -relaxivity) was assumed for the 1/T Ã 2 -dependence. Both T 1 -and T Ã 2 -relaxivity was assumed to be equal in blood and tissue and the conversion from relaxation rate to CA concentration was, therefore, not explicitly performed (because the relaxivity term then cancels out). The signal from a SPGR sequence is given by:
S SPGR ðtÞ5S 0 sina 12e
where S 0 is proportional to the thermal equilibrium magnetization, TR is the repetition time of the sequence, TE is the echo time, and a is the flip angle. T Ã 2 -effects were eliminated from Eq. [2] by estimating the initial signal intensity (SI) amplitude at each timepoint by least-squares fitting the multi-echo data to the assumed mono-exponential TE-dependent term:
Sðt; TE n Þ5S PD ðtÞe 
Here, S PD (t) is the estimated SI in the absence of T Ã 2 -effects at time t, S PD,0 is the average T Ã 2 -corrected SI at baseline, and T 1,0 is the pre-contrast longitudinal relaxation time. Precontrast T 1 -values were estimated in six patients using a modified Look-Locker inversion recovery (MOLLI) technique. Average T 1 -values ( 6 SD) were measured to 1528 6 40 ms in blood and 1354 6 103 ms in cancer tissue and used as a fixed T 1 -baseline for SPGR signal conversion in arteries and tumors, respectively. The measured T 1 -values in blood agreed well with literature values. 20 The DR 1 -time curves were then analyzed on a voxel-by-voxel basis using the extended Tofts pharmacokinetic model 7 :
C t ðtÞ5K trans C a ðtÞ e 2 K trans ve t 1v p C a ðtÞ
where represents the convolution operator and K trans is the volume transfer constant between the plasma volume, v p , and the extravascular extracellular space volume, v e . An arterial input function (AIF), C a , was obtained for each patient by extracting the DR 1 -time curves from an artery supplying the region of interest (ROI) using an automatic cluster-algorithm, 21 and an average AIF, estimated across all patients, was generated and used for quantitative analysis. Possible voxel-wise time-delays between the AIF and tissue response were automatically corrected for using a previously published approach. 22 Voxel-wise DR 1 -time curves were also analyzed by estimating the maximum peak enhancement (Peak enh ), time-to-peak (TTP), area under the curve (AUC), wash-in rate, and wash-out rate. The DR Ã 2 -time curves were analyzed using the established tracer kinetic model for DSC-MRI, 23 expressing the relationship between the tissue response and the AIF, yielding semi-quantitative analysis of blood flow (BF) and blood volume (BV). Corresponding mean transit time (MTT) is given by the central volume principle: MTT 5 BV/BF. To minimize contamination due to CA recirculation and leakage, the dynamic DR Ã 2 data was fitted to a gamma-variate function. 24, 25 For each patient, an AIF was obtained by extracting the DR Ã 2 -time curve from an artery supplying the ROI using an automatic cluster-algorithm. 21 Finally, the voxel-wise DR Ã 2 -time curves were analyzed by estimating the maximum dynamic peak change (R Ã 2 -peak enh ) and area under the curve (R Ã 2 -AUC). Due to the early onset of the first intravascular CA passage, only data from the first multi-echo segment was used for DSCbased analysis.
Statistical Analysis
Statistical analysis was performed using R version 2.10.1 (R Foundation for Statistical Computing, Vienna, Austria) and MATLAB R2015a version 8.5.0 (Mathworks, Inc., Natick, MA). The following pathological stages were grouped in the statistical analysis; T1 and T2, T3 and T4, and N1 and N2. Mann-Whitney U-test was used to evaluate associations between kinetic parameters and histopathologic data. A P-value < 0.05 was considered significant. Statistically significant parameters were further evaluated using receiver operator characteristic (ROC) curve statistics. A two-way intraclass correlation coefficient (ICC) for continuous variables was used to evaluate interobserver agreement for the measured whole-tumor VOIs. Table 2 summarizes the associations between kinetic parameters attainable with the dynamic contrast-based multi-echo sequence and histopathologic evaluation of the surgically resected specimens. Parameters showing statistically significant association with histopathology are presented as box plots in Figure 1 . For patients with histologically confirmed nodal metastasis, the primary tumor showed a significantly lower K trans (P 5 0.010 for reader 1 and P 5 0.043 for reader 2) and R Ã 2 -peak enh (P 5 0.005 for reader 1 and P 5 0.019 for reader 2) than patients without nodal metastasis. The corresponding area under the ROC curves (sensitivity, specificity) was 87 (71%, 90%) and 90 (86%, 90%) for reader 1, and 80 (86%, 80%) and 84 (86%, 80%) for reader 2, respectively. For reader 1, primary tumor wash-out also showed a significant association with nodal status (P 5 0.025), corresponding to an area under the ROC curve (sensitivity, specificity) of 83 (71%, 90%). Furthermore, for reader 1, T1 and T2 tumors showed a significantly higher k ep (P 5 0.045) and BV (P 5 0.021), compared with T3 and T4 tumors, corresponding to an area under the ROC curve (sensitivity, specificity) of 76 (78%, 75%) and 83 (71%, 90%), respectively. For reader 2, no significant associations were found between the DCE or DSC parameters and pT-stage. A mismatch between mrN and pN was found in 6 of 17 patients (35.3%), corresponding to an accuracy of 64.7%. Figure 2 shows DCE and DSC data obtained from the multi-echo sequence in a sample case, as well as resulting parametric maps merged as an overlay on a T 2 -weighted image. Figure 3 shows data from four cases and demonstrates the added value of DR Ã 2 analysis of the primary tumor in distinguishing patients with and without nodal metastasis. Figure 4 shows the measured AIF and VOI curves together with the corresponding gamma-variate fitted curve for a selected case. The figure demonstrates the importance of CA administration timing and acquisition length of the first multi-echo acquisition segment to include the first pass bolus. * The table shows mean ( 6 SD) parametric values based on whole-tumor medians extracted using VOI from reader 1 (A) and reader 2 (B).
Results
MRI Analysis
Interobserver Agreement
The ICC (95% confidence interval) between the two readers was 0.95 (0.87-0.98) for all whole-tumor VOIs, 0.81 (0.32-0.96) for T1-and T2-stage tumor VOIs, and 0.95 (0.80-0.99) for T3-and T4-stages tumor VOIs.
Simulations
Mann-Whitney U-test showed that there was no significant difference in the estimation of neither K trans (P 5 0.71), k ep (P 5 0.81), v e (P 5 0.99) nor v p (P 5 0.71) when using a continuous and a split dynamic MRI acquisition.
Discussion
Our study identified a significant association between both K trans and R Ã 2 -peak enh in primary rectal tumors and the nodal status evaluated by histopathology of the surgical specimen, showing an area under the ROC curve of 87% and 90% for reader 1, and 80% and 84% for reader 2, respectively. In comparison, standard radiologic assessments of nodal status agreed with histopathologic evaluation in 64.7% (11 of 17 patients). This finding is comparable to that of a recent meta-analysis (5). Low tumor K trans and R Ã 2 -peak enh were significantly associated with the presence of lymph node metastasis.
One hypothesis supporting these findings is that the peak change in tumor R Ã 2 reflects tissue blood supply, and that low R Ã 2 -peak enh may be associated with hypoxic tissue with insufficient blood flow. This hypothesis is supported by other results obtained in our study. First, tumor K trans , which is influenced by blood flow and permeability, was also significantly lower in patients with lymph node metastasis. Second, tumor BF and Peak enh was lower in N1 patients compared with N-patients, consistent with reduced perfusion in a high permeability (flow limited) regime. 7 The estimated plasma volumes (v p ) were, however, similar in N-and N1 patients, which may be unexpected given the reduced flow hypothesis. There may be several reasons for the apparent lack of v p differentiation between N1 and N-patients. First, changes in v p and perfusion could be partially decoupled in tumors due to changes in vascular structures leading to changes in CA MTT. In a situation where perfusion is decreased but MTT is proportionally increased, v p would remain unaffected (from the central volume principle: BF 5 BV 3 MTT). Second, estimations of v p from the extended Tofts model may be unstable or insensitive to small v p changes due to model over-fitting or water exchange effects reducing the first-pass amplitude of T 1 -weighted DCE data. 26 The association between R Ã 2 , tumor hypoxia and blood flow is also supported by previous literature, 27, 28 although their different MR data acquisition and analysis cannot be directly related to our parameter, R Ã 2 -peak enh . To further investigate our hypothesis and elucidate the exact mechanism behind the associations between low R Ã 2 -peak enh , low K trans and lymph node metastasis, supplementary studies are required. The nodal status represents a main prognostic marker for metastatic progression and unfavorable survival. A positive N-stage will also have implications for treatment, as these patients should be considered for neoadjuvant CRT, and extended pelvic surgery to include all lymph nodes. However, reliable staging of lymph nodes is one of the most challenging tasks in diagnostic imaging of rectal cancer. Our finding suggests that DCE-and DSC-MRI of rectal cancer may provide important indicators of lymph node status, thereby improving mrN staging prior to therapy. Similar to our findings, tumor K trans values have recently been shown to be lower in N1 patients compared with N0 patients. 29 To our knowledge, associations between DSC-MRI and histopathologic data have not been reported in rectal cancer patients. However, a recent study by Goh et al showed that primary colorectal tumor blood flow measured by perfusion computed tomography (CT) was significantly lower in patients with metastatic relapse compared with disease-free patients. 30 For one reader, our study also showed a significant association for k ep when comparing T1-and T2-versus T3-and T4-stage tumors, with a lower k ep being associated with higher tumor T-stage. This result is in agreement with that of a recent study showing a significantly higher mean k ep in T1 stage tumors compared with T2-4 stage tumors. 29 A difference was found between the two readers when evaluating the association between histopathologic data and the DCE-and DSC-MRI derived parameters. This may be caused by a lower interobserver agreement in T1-and T2-stage tumor volumes, compared with T3-and T4-stage tumor volumes. This difference is probably caused by difficulties in delineating small tumors. The findings of a recent meta-analysis of MRI tumor staging in rectal cancer support this view. They report a lower diagnostic accuracy of staging T1 and T2 tumors compared with T3 and T4 tumors. 31 Given that the multi-echo acquisition was run as part of a split-dynamic MRI framework, simulations were performed to investigate whether the splitting of dynamic time- series may influence the reliability of parameter estimation in comparison with a continous acquisition. According to our simulations, the split dynamic acquisition did not significantly affect the accuracy of kinetic parameter estimates compared with using a continuous acquisition. Uncertainties in the estimates were found to increase with increasing parametric value for both acquisition methods, with a somewhat larger error for the split dynamic approach. This may indicate that the splitting process reduces the sensitivity to accurately estimate extremely abnormal kinetic values. However, this difference was not statistically significant, and the findings suggest that essential information is not lost in the splitting process, and that a split dynamic approach will provide sufficient information of the contrast enhancement kinetics for clinically relevant parametric values.
Given the high vascular permeability in rectal cancer, the measured DSC data are likely contaminated by leakage effects that cannot be reliably removed by standard leakage correction approach (gamma variate fitting). 25 In theory, first-pass DR Ã 2 values could be strongly attenuated in the presence of CA extravasation due to loss of CA compartmentalization and consequent reduction in effective r Ã 2 -relaxivity. Leakage corrections based on kinetic modelling are successfully applied to brain DSC-MRI, 32 but these methods require access to reference data from a region with no CA extravasation and, hence, not applicable in noncentral 33 These more advance approaches were not tested in the current study due to limited signal-to-noise ratio (SNR) and additional modelling complexity due to variable temporal resolution. It should be noted that leakage effects alone are unlikely to explain the reduced R Ã 2 -peak enh in N1 patients compared with Npatients. Because N1 subjects also had lower K trans , it would be expected that leakage effects were less dominant in these patients and hence R Ã 2 -peak enh less under-estimated compared with the N-cases. Correction for CA leakage effects should, therefore, potentially lead to an even greater differentiation in perfusion metrics between the N1 and Npatients. R Ã 2 peak enh can be considered a pseudo-marker for tissue perfusion in the limiting case when the AIF can be approximated by a delta function. In practice, CA dispersion requires deconvolution of the AIF from the tissue response to derive semi-quantitative estimates of perfusion (BF). 23 Deconvolution-based perfusion (BF) estimates (and corresponding estimated of BV and MTT) were additionally obtained in the present work. With the exception of BV, which was significantly lower T3/T4-compared with T1/ T2-stage tumors, these parameters did not show any statistically significant association with histopathological confirmed T-or N-stages. Presence of significant leakage effects is clearly a confounding factor in this analysis, but it may still be surprising that BF was less sensitive than R Ã 2 peak enh because the two metrics should be equally affected by leakage effects. Furthermore, BF should in theory be less dependent on patient-specific variations in CA injection profiles, cardiac output, and other confounding factors. The apparent lack of sensitivity of BF in predicting T-or N-stage could be partly due to inaccurate AIF determination, and the fact that AIF deconvolution is sensitive to noise and insufficient SNR in the DSC data could thus result in low accuracy in the resulting BF estimates. 34 Due to a relatively long TE, the first echo may be significantly affected by T Ã 2 signal attenuation, especially for high CA concentrations in blood, which in turn results in errors in the DCE-derived parameters. Given the multi-echo acquisition, T Ã 2 signal attenuation in the DCE data was corrected for by extrapolation back to TE 5 0, yielding the initial SI amplitude in the absence of T Ã 2 -effects. This approach has recently been shown to reduce errors in DCEderived parameters. 35 While this study suggests that DCE-and DSC-MRI data acquired by a multi-echo sequence may aid the diagnostics of N-status in rectal cancer patients, several potential study limitations needs to be addressed. First, the results must be interpreted in light of the limited sample size of this single center study. Further studies will be performed to test our findings and evaluate the robustness and clinical utility in a larger patient cohort. Second, motion artifacts due to peristalsis represent a problem when acquiring dynamic data. To reduce motion artifacts by peristalsis, glucagon and BuscopanV R were routinely administered immediately before the patient was centered in the scanner.
In this work, 5 of 24 patients were excluded due to motion artifacts, and motion correction strategies should be implemented when acquiring dynamic data from the rectum. Next, susceptibility effects and consequent T Ã 2 -induced signal loss due to air cavities may be a problem in this anatomical region. Furthermore, as the CA gradually accumulates in the bladder, susceptibility artifacts may occur in the late postcontrast phase, affecting the DR Ã 2 measurements in the surrounding tissue. However, due to the early onset of the first intravascular CA passage, early postcontrast data may be sufficient for the DSC analysis. Finally, due to limited spatial resolution in the multi-echo sequence, the measured SI in each voxel may be affected by partial volume effects. This can particularly be a problem when measuring an AIF from smaller arteries supplying the tissue of interest.
In conclusion, a dynamic contrast-based multi-echo MRI technique has been implemented and tested in rectal cancer patients. A significant association was found between both primary tumor K trans and R Ã 2 -peak enh and nodal status, suggesting that a combined DCE-and DSC-MRI acquisition may help to determine N-status in diagnostic rectal cancer staging and, hence, enable improved patient stratification to multimodal treatment.
